Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Beyond PD-1: Roche Maps Further Checkpoints On Cancer Immune Cycle

Executive Summary

Roche gave updates on its immunotherapy research at ASCO, setting the stage for an ambitious slate of combination trials with the company's PD-L1 inhibitor atezolizumab.

Advertisement

Related Content

Roche’s Immuno-Oncology Arsenal: PD-L1 And Beyond
Roche's Oncology Strategy: The Long Game Comes Into Focus

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register